Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Pavol Kudela"'
Publikováno v:
Applied Sciences, Vol 13, Iss 14, p 8054 (2023)
Currently, the largest milestone to successfully bring products to market is to shorten the production time interval, so the production of any product should be very fast. Customers are far more demanding and recently prefer the option to customize p
Externí odkaz:
https://doaj.org/article/08b8f01b23f24f8c8240b180c75524f8
Publikováno v:
Applied Sciences, Vol 12, Iss 9, p 4376 (2022)
Preservation of cultural heritage plays an important role in society, significantly contributing to its sustainability, which is important for human development and quality of life. The issue of cultural heritage digitization has recently been the su
Externí odkaz:
https://doaj.org/article/07c9386226e14b9a8e999b76ffc05770
Autor:
Jieling Lim, Vanessa Hui Qi Koh, Sharol Su Lei Cho, Balamurugan Periaswamy, Dawn Poh Sum Choi, Maurizio Vacca, Paola Florez De Sessions, Pavol Kudela, Werner Lubitz, Giorgia Pastorin, Sylvie Alonso
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Tuberculosis (TB) pathogenesis is characterized by inadequate immune cell activation and delayed T cell response in the host. Recent immunotherapeutic efforts have been directed at stimulating innate immunity and enhancing interactions between antige
Externí odkaz:
https://doaj.org/article/a8c2fa4f44c849e784c7001d77def66b
Autor:
Diana Groza, Sebastian Gehrig, Pavol Kudela, Martin Holcmann, Christine Pirker, Carina Dinhof, Hemma H. Schueffl, Marek Sramko, Julia Hoebart, Fatih Alioglu, Michael Grusch, Manfred Ogris, Werner Lubitz, Bernhard K. Keppler, Irena Pashkunova-Martic, Christian R. Kowol, Maria Sibilia, Walter Berger, Petra Heffeter
Publikováno v:
OncoImmunology, Vol 7, Iss 5 (2018)
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and a major cause of cancer mortality worldwide. At late stage of the disease CRC often shows (multiple) metastatic lesions in the peritoneal cavity which cannot be efficiently tar
Externí odkaz:
https://doaj.org/article/5806f5f02cb14776aff768ab520ce02a
Publikováno v:
Advances in Electrical and Electronic Engineering, Vol 3, Iss 2, Pp 265-268 (2004)
High quality silicon epitaxial layers are inevitable in bipolar and/or unipolar technology. However, its properties are not as easy characterized as those of bulk material. The recombination lifetime is dominated by surface/interface recombination fo
Externí odkaz:
https://doaj.org/article/358d28fe8862451bac6f68c3af4fdde7
Autor:
Simona, Borstnar, Marketa, Palacova, Aleksandra, Łacko, Constanta, Timcheva, Einav Nili, Gal-Yam, Konstantinos, Papazisis, Juraj, Beniak, Pavol, Kudela, Gábor, Rubovszky
Publikováno v:
Radiology and Oncology. 56:238-247
Background The CDK4/6 inhibitor, ribociclib in combination with endocrine therapy significantly improved progression-free survival in the first line setting in post-menopausal patients with HR+/HER2− advanced breast cancer (ABC) in a pivotal phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6bef7489d337e5c12a07efe7583179c
https://doi.org/10.2478/raon-2022-0020
https://doi.org/10.2478/raon-2022-0020
Autor:
Werner Lubitz, Karolina Žilionytė, Olha Karaman, Pavol Kudela, Hryhorii Potebnya, Adas Darinskas, Hennadii Didenko, Vladimir Kulchitsky, Vasyl Chekhun, Vita Pašukonienė, Marina Derevyanko, Edita Miseikyte-Kaubriene, Jan Aleksander Kraśko, Iosif Zalutsky, Svetlana Rjabceva, Marius Strioga
Publikováno v:
Oncology Reports. 37:171-178
Instead of relying on external anticancer factors for treatment, immunotherapy utilizes the host's own immune system and directs it against given tumour antigens. This study demonstrated that it is possible to overcome the documented immunosuppressiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bee033c334bce636b18293e75ee33cff
https://doi.org/10.3892/or.2016.5252
https://doi.org/10.3892/or.2016.5252
Autor:
Marius Strioga, Neringa Dobrovolskienė, Vita Pašukonienė, E. Mišeikytė-Kaubrienė, Živilė Gudlevičienė, Agata Mlynska, Werner Lubitz, Pavol Kudela, Virgil E.J.C. Schijns, Jan Aleksander Kraśko, Karolina Žilionytė, Adas Darinskas
Publikováno v:
Vaccine, 36(29), 4171-4180
Vaccine 36 (2018) 29
Vaccine 36 (2018) 29
Cancer immunotherapy with dendritic cell (DC)-based vaccines has been used to treat various malignancies for more than two decades, however generally showed a limited clinical success. Among various factors responsible for their modest clinical activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0713f84a1810d08f50ebda8a2d1f6304
https://research.wur.nl/en/publications/tumor-lysate-loaded-bacterial-ghosts-as-a-tool-for-optimized-prod
https://research.wur.nl/en/publications/tumor-lysate-loaded-bacterial-ghosts-as-a-tool-for-optimized-prod
Autor:
Renata Hezova, Werner Lubitz, Pavlina Turanek-Knotigova, Jana Gabkova, Pavol Kudela, Marius Strioga, Jaroslav Michálek
Publikováno v:
Cancer immunology, immunotherapy : CII. 66(2)
The natural adjuvant properties of bacterial ghosts (BGs) lie within the presence of intact pathogen-associated molecular patterns on their surface. BGs can improve the direct delivery, natural processing and presentation of target antigens within de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b109bf2b57303afb75529196454564c
https://pubmed.ncbi.nlm.nih.gov/27864613
https://pubmed.ncbi.nlm.nih.gov/27864613
Autor:
Alena Atrasheuskaya, Eugenij Bukin, Pavol Kudela, Georgy M. Ignatyev, Werner Lubitz, Ulrike Beate Mayr
Publikováno v:
Microbial Biotechnology. 5:283-294
Bacterial ghosts (BGs) have been applied through oral, aerogenic, intraocular or intranasal routes for mucosal immunization using a wide range of experimental animals. All these applications required a booster after primary immunization to achieve pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2115d6ecc2fa4b2c35d76463a4099cbb
https://doi.org/10.1111/j.1751-7915.2011.00316.x
https://doi.org/10.1111/j.1751-7915.2011.00316.x